<DOC>
	<DOCNO>NCT01217255</DOCNO>
	<brief_summary>Because high cost , person hemophilia many develop country afford adequate treatment . For example , many person hemophilia India China rarely treat factor replacement response bleeds , result many develop significant arthropathy disability . A pilot study China estimate mean Hemophilia Joint Health Score ( HJHS ) 13.1 ( SD 9.03 ) suggest child highly prevalent , severe joint disease . The lack relationship HJHS treatment history suggest overall inadequate therapy . The propose study quantify burden arthropathy , physical disability , quality life ( QoL ) boys hemophilia Brazil - comprehensive treatment begin widely available . This study also provide opportunity compare outcomes observe Canada , dominant therapy become life-long prophylaxis .</brief_summary>
	<brief_title>Comparing Burden Illness Hemophilia Developing Developed World</brief_title>
	<detailed_description>In order quantify burden illness hemophilia , study response different treatment , necessary quantitative outcome measure high validity reliability . The International Prophylaxis Study Group ( IPSG - chair Dr. Victor Blanchette ) establish 2001 state purpose develop test outcome tool purpose . The group develop magnetic resonance imaging ( MRI ) score quantify arthropathy ( represent domain structure function domain ICF framework ) , quantitative physical examination score , Hemophilia Joint Health Score HJHS , replace old less sensitive World Federation Hemophilia ( WFH ) score ( represent domain structure function ICF ) . In addition Canadian investigator also develop quality life measure boys hemophilia , Canadian Hemophilia Outcomes Kids ' Life Assessment Tool CHO-KLAT ( represent domain participation ICF ) . We use tool , validate measure , begin determine burden hemophilia Brazil compare burden disease Canada . Additionally , use study demonstrate validity tool Brazilian population .</detailed_description>
	<mesh_term>Hemophilia A</mesh_term>
	<mesh_term>Hemophilia B</mesh_term>
	<criteria>Inclusion criterion Hemophilia A B moderate severe determine serum factor activity â‰¤ 5 % Age 7 18 yr . inclusive At least one parent guardian fluent write Portuguese English able complete study outcome questionnaire . Exclusion criterion None ( Children inhibitor allow study 2 reason : ) study aim document health person hemophilia generalizable way , ii ) child inhibitor test do . )</criteria>
	<gender>Male</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Hemophilia</keyword>
	<keyword>Burden Illness</keyword>
	<keyword>Pediatric</keyword>
	<keyword>Quality Life</keyword>
	<keyword>Disability</keyword>
	<keyword>Participation</keyword>
</DOC>